Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Buy now fake rolex


Novo's bumper baby policy

Posted 18 June 2021 AM

Novo Nordisk has announced it will offer a minimum of eight weeks paid leave to all non-birthing parents globally, regardless of gender.

The new policy - announced this week to coincide with Pride month - will come into effect from January 2022 and has the ringing endorsement of staff.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
Pitfalls may plague NMP review
With an election in play, will it arrive too late?
Approvals Action
First copy of Halaven ticked
Along with other generics of already PBS-listed drugs